Ironwood Pharmaceuticals Q3 2024 Investor Update November 7, 2024 1 | --- | --- | |--------------|-------| | | | | | | | | | | | | | | | | | | | | | | Introduction | | | | | | Matt Roache | | | | | | | | | | | | | | | | | | | 2 | Safe Harbor Statement 3 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability ...

Third Quarter 2024 Earnings Supplemental November 7, 2024 Safe Harbor Statement This presentation contains, or incorporates by reference, not only historical information, but also forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from our beliefs, expectations, estimates, projections and illustrations and, consequently, you should not rely on these forward-l ...

| --- | --- | --- | |--------------------------------|-------|-------------------------| | | | | | T | | M | | L | 7 | is MEDICAL LEAR w / ปรี่สี | | GFIGS EarningsPresentation | | | DISCLAIMER Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by FIGS, Inc. (the "Company") or any officer, director, employee, agent or advisor of the Company. This presentation does not purport to be all inclusive or to contain all of the information you may desir ...

▲AXON INVESTOR PRESENTATION AXON ENTERPRISE | NOVEMBER 2024 Safe-harbor statement Forward-looking statements in this letter include, without limitation, statements regarding: proposed products and services and related development efforts and activities; expectations about the market for our current and future products and services, including statements related to our user base and customer profiles; the impact of pending litigation; strategies and trends relating to subscription plan programs and revenues; ...

Third Quarter 2024 Financial Results November 6, 2024 Cautionary Note Regarding Forward-Looking Statements This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, expectation as to the closing and settlement date for the 2029 Notes and the quotations of management. These ...

| --- | --- | --- | --- | |----------|------------------------------------------|----------------------------------------|------------------------------------------| | Contact: | Deric Eubanks | Laken Avonne Rapier | NEWS RELEASE \nJoseph Calabrese | | | Chief Financial Officer (972) 490-9600 | Media Contact LRapier@ashfordinc.com | Financial Relations Board (212) 827-3772 | BRAEMAR HOTELS & RESORTS REPORTS THIRD QUARTER 2024 RESULTS DALLAS – November 6, 2024 – Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Br ...

MIN PRIMO WATER" 3rd QUARTER 2024 RESULTS November 7, 2024 98 % B Cautionary Statements 2 Safe Harbor Statement This presentation contains forward-looking statements and forward-looking information within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and applicable Canadian securities laws conveying management's expectations as to the future based on plans, estimates and projections at the time Primo Water Corporation (the "Company," "Primo Wate ...

PRIVI 1 3 rd Quarter 2024 Results November 7, 2024 Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2024 financial guidance and other projections and forecasts. These forward-looking statements invo ...

| --- | --- | --- | |-----------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | PacBio Q3 2024 Earnings | | | | | | | | Presentation | | | | November 7, 2024 Third Quarter 2024 Earnings Call | | | | | | | | | | | | | | | | | | | 1 Statement regarding use of non‐GAAP financial measures PacBio reports non‐GAAP results for basic and diluted net income and loss per share, net income, net loss, gross margins, gross profit and operating expenses in add ...

arlo " Investor Presentation Q3 2024 ©2024 – ALL RIGHTS RESERVED SAFE HARBOR DISCLOSURE This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words "anticipate," "expect," "believe," "will," "may," "should," "estimate," "project," "outlook," "forecast" or other similar words are used to identify such forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. Th ...